Mglur1 (Grm1) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
mGluR1 (GRM1) neurons represent a population of neurons that express the metabotropic glutamate receptor 1 (mGluR1), also known as GRM1. This receptor is a class C G-protein coupled receptor that plays crucial roles in synaptic transmission, plasticity, and cerebellar function. mGluR1 is particularly abundant in cerebellar Purkinje cells, where it mediates forms of synaptic plasticity essential for motor learning. [1]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Allen Brain Cell Atlas | Search | mGluR1 (GRM1) Neurons |
| Cell Ontology (CL) | Search | Check classification |
| Human Cell Atlas | Search | Check expression data |
| CellxGene Census | Search | Check cell census |
The GRM1 gene encodes the mGluR1 receptor, a 1194-amino acid protein. The GRM1 protein belongs to the group I metabotropic glutamate receptor family, which also includes mGluR5 (GRM5). The receptor consists of: [2]
mGluR1 activates multiple intracellular signaling pathways: [3]
mGluR1 is expressed in several brain regions: [4]
Cerebellum
Cerebral Cortex
Other Regions
mGluR1 mediates several forms of synaptic plasticity:
Long-term Depression (LTD)
Long-term Potentiation (LTP)
mGluR1 in cerebellar Purkinje cells is essential for:
In cortical and thalamic circuits, mGluR1 contributes to:
mGluR1-expressing neurons are implicated in multiple neurodegenerative and neurological disorders. The receptor's role in synaptic plasticity, calcium signaling, and excitotoxicity makes it a key player in disease pathogenesis.
mGluR1 dysfunction has been increasingly recognized in Alzheimer's disease pathology: [5]
Amyloid-beta Effects
Tau Pathology Interactions
Therapeutic Implications
mGluR1 plays a complex role in Parkinson's disease pathophysiology: [6]
Basal Ganglia Circuitry
Dopaminergic Degeneration
L-DOPA-induced Dyskinesias
mGluR1 signaling is altered in Huntington's disease: [7]
Striatal Dysfunction
Therapeutic Targeting
Group I mGluRs, including mGluR1, play dual roles in excitotoxicity: [8]
Excitotoxic Mechanisms
Neuroprotective Pathways
mGluR1 is increasingly recognized for its role in neuroinflammation: [9]
Microglial Interactions
Inflammatory Disease Interactions
Migraine: mGluR1 is implicated in trigeminal nociception and cortical spreading depression: [10]
Essential Tremor: Altered cerebellar mGluR1 signaling contributes to oscillatory dysfunction: [11]
Schizophrenia: mGluR1 hypofunction may contribute to prefrontal cortex dysfunction
Autism Spectrum Disorders: GRM1 variants affect synaptic plasticity and social behavior
mGluR1-mediated calcium signaling is crucial:
mGluR1 activates multiple pathways:
mGluR1 agonists and PAMs have been investigated for:
mGluR1 antagonists show promise for:
Key techniques for studying mGluR1 neurons:
Animal models used in research:
Induced pluripotent stem cell (iPSC) derived neurons:
mGluR1 (GRM1) neurons represent a critical population in the central nervous system with roles in synaptic plasticity, motor control, and cognitive function. Dysregulation of mGluR1 signaling contributes to multiple neurodegenerative and neurological disorders, making it an important therapeutic target. Current research focuses on developing selective modulators and understanding the complex signaling networks involving mGluR1 in disease contexts.
Kano et al. mGluR1 signaling in cerebellar Purkinje cells (2022). 2022. ↩︎
Bocchio et al. Group I metabotropic glutamate receptors in synaptic plasticity (2021). 2021. ↩︎
Wang et al. GRM1 mutations and ataxia (2020). 2020. ↩︎
Hensch et al. mGluR1 and cortical circuit development (2019). 2019. ↩︎
Ishida et al. mGluR1 dysfunction in Alzheimer's disease models (2023). 2023. ↩︎
Ucci et al. mGluR1 and Parkinson's disease (2022). 2022. ↩︎
Chen et al. mGluR1 in Huntington's disease (2023). 2023. ↩︎
Kumar et al. Group I mGluRs in excitotoxicity (2022). 2022. ↩︎
Liu et al. mGluR1 and neuroinflammation (2024). 2024. ↩︎
Patel et al. mGluR1 signaling in migraine pathophysiology (2023). 2023. ↩︎
Martinez et al. mGluR1 in essential tremor (2022). 2022. ↩︎